SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Bos K)
 

Search: WFRF:(Bos K) > (2020-2024) > Serum neurofilament...

  • Brune, S. (author)

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • 2022-06-04
  • SAGE Publications,2022

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/320064
  • https://gup.ub.gu.se/publication/320064URI
  • https://doi.org/10.1177/13524585221097296DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: Serum neurofilament light (sNfL) chain is a promising biomarker reflecting neuro-axonal injury in multiple sclerosis (MS). However, the ability of sNfL to predict outcomes in real-world MS cohorts requires further validation. Objective: The aim of the study is to investigate the associations of sNfL concentration, magnetic resonance imaging (MRI) and retinal optical coherence tomography (OCT) markers with disease worsening in a longitudinal European multicentre MS cohort. Methods: MS patients (n = 309) were prospectively enrolled at four centres and re-examined after 2 years (n = 226). NfL concentration was measured by single molecule array assay in serum. The patients' phenotypes were thoroughly characterized with clinical examination, retinal OCT and MRI brain scans. The primary outcome was disease worsening at median 2-year follow-up. Results: Patients with high sNfL concentrations (> 8 pg/mL) at baseline had increased risk of disease worsening at median 2-year follow-up (odds ratio (95% confidence interval) = 2.8 (1.5-5.3), p = 0.001). We found no significant associations of MRI or OCT measures at baseline with risk of disease worsening. Conclusion: Serum NfL concentration was the only factor associated with disease worsening, indicating that sNfL is a useful biomarker in MS that might be relevant in a clinical setting.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Hogestol, E. A. (author)
  • Benavent, S. A. D. (author)
  • Berg-Hansen, P. (author)
  • Beyer, M. K. (author)
  • Leikfoss, I. S. (author)
  • Bos, S. D. (author)
  • Sowa, P. (author)
  • Brunborg, C. (author)
  • Andorra, M. (author)
  • Valdeolivas, I. P. (author)
  • Asseyer, S. (author)
  • Brandt, A. (author)
  • Chien, C. (author)
  • Scheel, M. (author)
  • Blennow, K. (author)
  • Zetterberg, Henrik,1973Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry(Swepub:gu)xzethe (author)
  • de Rosbo, N. K. (author)
  • Paul, F. (author)
  • Uccelli, A. (author)
  • Villoslada, P. (author)
  • Berge, T. (author)
  • Harbo, H. F. (author)
  • Göteborgs universitetInstitutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi (creator_code:org_t)

Related titles

  • In:Multiple Sclerosis Journal: SAGE Publications28:121352-45851477-0970

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view